Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review

ED Lunde, PB Nielsen, S Riahi, TB Larsen… - Expert review of …, 2018 - Taylor & Francis
Background: Atrial fibrillation (AF) is a growing epidemic and evidence of a relationship to
socioeconomic status (SES) is inconsistent. We aimed to summarize the literature about …

Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008–2015): A cross …

L Ibáñez, M Sabaté, X Vidal, E Ballarin… - British Journal of …, 2019 - Wiley Online Library
Aims To estimate the incidence of direct oral anticoagulant drug (DOAC) use in patients with
nonvalvular atrial fibrillation and to describe user and treatment characteristics in 8 …

eHealth tools to provide structured assistance for atrial fibrillation screening, management, and Guideline‐Recommended therapy in metropolitan general practice: the …

J Orchard, L Neubeck, B Freedman, J Li… - Journal of the …, 2019 - Am Heart Assoc
Background This eH ealth implementation study aimed to evaluate strategies to promote
opportunistic atrial fibrillation (AF) screening using electronic screening prompts and …

Atrial fibrillation screen, management, and guideline‐recommended therapy in the rural primary care setting: a cross‐sectional study and cost‐effectiveness analysis …

J Orchard, J Li, B Freedman, R Webster… - Journal of the …, 2020 - Am Heart Assoc
BACKGROUND Internationally, most atrial fibrillation (AF) management guidelines
recommend opportunistic screening for AF in people≥ 65 years of age and oral …

Primary nonadherence to oral anticoagulants in patients with atrial fibrillation: real-world data from a population-based cohort

CL Rodriguez-Bernal, S Peiró, I Hurtado… - Journal of managed …, 2018 - jmcp.org
BACKGROUND: Primary nonadherence (not filling a first prescription) is an important yet
unstudied aspect of adherence to oral anticoagulant (OAC) therapy. OBJECTIVE: To …

Evolving trends in consumption of direct oral anticoagulants in 65 countries/regions from 2008 to 2019

VKC Yan, HL Li, L Wei, MRJ Knapp, ICK Wong… - Drugs, 2023 - Springer
Abstract Background Direct oral anticoagulants (DOACs) have been increasingly utilised
over warfarin. However, little is known about the relative consumption trends and costs of …

Disparities and temporal trends in the use of anticoagulation in patients with ischemic stroke and atrial fibrillation

NB Sur, K Wang, MR Di Tullio, CM Gutierrez, C Dong… - Stroke, 2019 - Am Heart Assoc
Background and Purpose—Ischemic stroke (IS) secondary to atrial fibrillation (AF) is largely
preventable with the use of anticoagulation. We sought to identify race-ethnicity and sex …

Impact of renal function on outcomes with edoxaban in real-world patients with atrial fibrillation: a nationwide cohort study

HT Yu, PS Yang, TH Kim, E Jang, D Kim, JS Uhm… - Stroke, 2018 - Am Heart Assoc
Background and Purpose—Edoxaban is a direct oral factor Xa inhibitor with proven efficacy
and safety among patients with atrial fibrillation. Concerns have been raised about an …

Uptake of a primary care atrial fibrillation screening program (AF-SMART): a realist evaluation of implementation in metropolitan and rural general practice

J Orchard, J Li, R Gallagher, B Freedman, N Lowres… - BMC family …, 2019 - Springer
Background Screening for atrial fibrillation (AF) in people aged≥ 65 years is recommended
by international guidelines. The Atrial Fibrillation Screen, Management And guideline …

Dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a Danish nationwide cohort study

LY Xing, CA Barcella, C Sindet-Pedersen… - Thrombosis …, 2019 - Elsevier
Introduction To investigate the patterns of dose reduction of non-vitamin K antagonist oral
anticoagulants (NOAC) in patients with atrial fibrillation (AF). Materials and methods Using …